CompletedPhase 1NCT02270489

Study Assessing Safety and Therapeutic Activity of AFFITOPE® PD01A and PD03A in Patients With Early MSA

Studying Multiple system atrophy

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Affiris AG
Principal Investigator
Wassilios Meissner, MD, PhD
University Hospital Bordeaux (Pellegrin Hospital), Bordeaux 33076, France
Intervention
AFFITOPE® PD01A + Adjuvant(biological)
Enrollment
30 target
Eligibility
30-75 years · All sexes
Timeline
2014 – 2017

Study locations (2)

Collaborators

University Hospital, Bordeaux · Institut National de la Santé Et de la Recherche Médicale, France · Forschungszentrum Juelich · University Hospital, Toulouse

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02270489 on ClinicalTrials.gov

Other trials for Multiple system atrophy

Additional recruiting or active studies for the same condition.

See all trials for Multiple system atrophy →

← Back to all trials